27th May 2025, Tuesday

TechPharus

Latest Posts

HealthTech News

  • Why carrying spuds and playing sudoku could be good measures of your overall health
    on May 27, 2025 at 7:00 pm

    While aging is inevitable, aging well is something we can influence. It’s not just about the number of candles on your birthday cake—it’s whether you’ve got the puff to blow them out, the balance to carry the cake and the memory to remember why you’re celebrating.

  • Model solves key challenge in combining mismatched geographic health data
    on May 27, 2025 at 6:51 pm

    Combining data across mismatched maps is a key challenge in global health and environmental research. A powerful modeling approach has been developed to enable faster and more accurate integration of spatially misaligned datasets, including air pollution prediction and disease mapping. The study is published in the journal Stochastic Environmental Research and Risk Assessment.

  • Post-kidney transplant adverse outcomes increased with BMI-BSA obesity
    on May 27, 2025 at 6:50 pm

    Combined body mass index (BMI)-body surface area (BSA) obesity is associated with an increased risk for post-kidney transplant (KT) adverse outcomes, according to a study published online May 21 in Transplantation Direct.

  • RSV immunization has saved Australia millions in hospital costs
    on May 27, 2025 at 6:50 pm

    A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already resulted in 57% lower than expected hospitalizations in WA, saving the health system $6.2–6.9 million, according to Australian experts. The experts say the availability of vaccines is “an era-defining advancement in RSV prevention.”

  • Combining stem cell engineering and drug therapy to suppress abnormal bone formation
    on May 27, 2025 at 6:44 pm

    A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has developed a promising new therapeutic strategy for fibrodysplasia ossificans progressiva (FOP)—a rare and severely disabling genetic disorder—by combining low-dose rapamycin with mesenchymal stem/stromal cells (MSCs) derived from induced pluripotent stem (iPS) cells. The paper is published in the journal JBMR Plus.